Xbiotech Inc (XBIT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -38,531 | -24,557 | -32,900 | -17,414 | -11,221 |
| Depreciation Amortization | 1,745 | 1,744 | 2,614 | 2,648 | 2,238 |
| Accounts receivable | N/A | N/A | N/A | 4,113 | -4,113 |
| Accounts payable and accrued liabilities | -364 | 91 | 357 | -514 | -334 |
| Other Working Capital | -1,459 | 2,719 | 7,600 | 4,685 | -68,684 |
| Other Operating Activity | 7,646 | 1,278 | 7,505 | 75,927 | 16,965 |
| Operating Cash Flow | $-30,963 | $-18,725 | $-14,824 | $69,445 | $-65,149 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 61,859 | -63,307 | N/A | N/A |
| PPE Investments | -1,304 | -362 | -585 | -3,525 | -3,727 |
| Investing Cash Flow | $-1,304 | $61,497 | $-63,892 | $-3,525 | $-3,727 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 10,250 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 200 | 5 | N/A | 7,995 | -409,724 |
| Dividend Paid | N/A | N/A | N/A | -75,003 | N/A |
| Other Financing Activity | 0 | -14 | 0 | 0 | 0 |
| Financing Cash Flow | $10,450 | $-9 | $N/A | $-67,008 | $-409,724 |
| Exchange Rate Effect | -5,529 | -46 | -961 | 705 | 1,372 |
| Beginning Cash Position | 200,023 | 157,306 | 236,983 | 237,366 | 714,594 |
| End Cash Position | 172,677 | 200,023 | 157,306 | 236,983 | 237,366 |
| Net Cash Flow | $-27,346 | $42,717 | $-79,677 | $-383 | $-477,228 |
| Free Cash Flow | |||||
| Operating Cash Flow | -30,963 | -18,725 | -14,824 | 69,445 | -65,149 |
| Capital Expenditure | -1,304 | -362 | -585 | -3,525 | -3,727 |
| Free Cash Flow | -32,267 | -19,087 | -15,409 | 65,920 | -68,876 |